Stock Market & Financial News
Are Investors Undervaluing Americold Realty Trust (COLD) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
COLD +1.76% Are Computer and Technology Stocks Lagging Hewlett Packard (HPE) This Year?
Here is how Hewlett Packard Enterprise (HPE) and ASE Technology Hldg (ASX) have performed compared to their sector so far this year.
HPE +2.2% Are Investors Undervaluing Evertec (EVTC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
EVTC -2.7% Here's Why Solventum (SOLV) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
SOLV -2.33% 
Should Value Investors Buy A.P. Moller-Maersk (AMKBY) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
AMKBY -0.18% 
Is L.B. Foster (FSTR) Stock Outpacing Its Basic Materials Peers This Year?
Here is how L.B. Foster (FSTR) and Innospec (IOSP) have performed compared to their sector so far this year.
FSTR -0.57% 
Has Vestis Corporation (VSTS) Outpaced Other Industrial Products Stocks This Year?
Here is how Vestis (VSTS) and Vestas Wind Systems AS (VWDRY) have performed compared to their sector so far this year.
VSTS +1.37% 
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
ZBH -0.25% 
Is AAR (AIR) Stock Outpacing Its Aerospace Peers This Year?
Here is how AAR (AIR) and Curtiss-Wright (CW) have performed compared to their sector so far this year.
AIR -1.47% 
Is INPLAY OIL CP (IPOOF) Outperforming Other Oils-Energy Stocks This Year?
Here is how INPLAY OIL CP (IPOOF) and Paramount Resources (PRMRF) have performed compared to their sector so far this year.
IPOOF +4.54% 
Is Franklin Resources Inc (BEN) Outperforming Other Finance Stocks This Year?
Here is how Franklin Templeton (BEN) and Bank of Montreal (BMO) have performed compared to their sector so far this year.
BEN -1.46% 
Are Business Services Stocks Lagging Ralliant Corporation (RAL) This Year?
Here is how Ralliant (RAL) and Remitly Global, Inc. (RELY) have performed compared to their sector so far this year.
RAL +1.29% 
Tenet Healthcare (THC) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
THC -0.81% 
FTC Requests Additional Information Regarding Fertitta, Caesars Merger
The request comes after billionaire Tilman Fertitta in May reached an agreement to buy Caesars Entertainment for $5.7 billion.
FTC -0.26% 
Avalanche Treasury CEO warns AI agents may strain blockchain capacity
AI agents' rapid growth could reshape blockchain adoption, emphasizing the need for scalable, isolated networks to handle increased demand. Avalanche Treasury CEO warns AI agents may strain blockchain capacity.
XLII: Positive Industrial Sector Dynamics Enhance Income Portfolios
The State Street Industrial Select Sector SPDR Premium Income ETF offers income-focused exposure to the industrial sector, diversifying tech-heavy portfolios. XLII delivers monthly income with an average yield of 13.09% and reasonable NAV growth, supported by strong industrial sector tailwinds. A call spread strategy allows for more underlying appreciation and lower volatility compared to XLI, though upside is capped.
XLII -0.84% 
Caris Life Sciences: Diagnostics Growth With Room To Run
Caris Life Sciences has an already established profiling business that provides revenue and cash flows for its expanding diagnostics portfolio. CAI reuses molecular data and clinical relationships, leveraging them into new tests that I believe should increase their shareholder value in the long run. CAI's Detect broadens its growth potential. However, we still need to see if their cash-pay adoption and marketing expenses pay off as intended.
CAI +0.91% 
Flowers Foods Faces Volume Pressure: Can Innovation Revive Growth?
Flowers Foods turns to smaller loaves, sourdough and protein products after sharp volume declines reshape demand for fresh packaged bread.
FLO -4.21% 
After Plunging 7.3% in 4 Weeks, Here's Why the Trend Might Reverse for Paccar (PCAR)
Paccar (PCAR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
PCAR -2.4% 
UMB (UMBF) Loses 8.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
UMB (UMBF) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
UMBF -0.48% 
Here's Why Daktronics (DAKT) is Poised for a Turnaround After Losing 10.0% in 4 Weeks
Daktronics (DAKT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
DAKT +5.86% 
Down 20.1% in 4 Weeks, Here's Why Installed Building Products (IBP) Looks Ripe for a Turnaround
Installed Building Products (IBP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
IBP +0.5% 
Hyundai Inks Avalanche Deal. Will AVAX Benefit From It?
Hyundai's representative says Avalanche may play a key part in the car-maker's revamped economic model.
Fluence Energy Shares Plummet after Guidance Cut
Shares of Fluence Energy Inc. (NASDAQ:FLNC) are under heavy pressure today, down 16.8% at $7.53, earlier tapping a fresh annual low of $7.01.
FLNC -1.93% 
Generac Stock Soars on $8B Deal to Sell Amazon Generators to Power Data Centers
Shares of Generac are surging after the energy hardware maker announced a multi-billion dollar deal with Amazon.
GNRC -0.59% 
Lawmakers pass bill to freeze federal Bitcoin holdings for two decades
ARMA would lock qualifying reserve Bitcoin in place from enactment and require annual audited reporting, while purchases remain a study.
CAKE Stock Up 72% in 6 Months: Can Its Discount P/E Fuel More Gains?
CAKE stock has surged 72% in six months, but its below-industry P/E, strong Q2 results and rising earnings estimates could fuel further gains.
CAKE -3.62% 
Wall Street Analysts Think CRISPR Therapeutics (CRSP) Is a Good Investment: Is It?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
CRSP -1.2% 
Is Humacyte, Inc. (HUMA) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
HUMA +5.33% 
Diebold Nixdorf, Incorporated (DBD) Is Considered a Good Investment by Brokers: Is That True?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
DBD -0.12% 
